Sign Up to like & get
recommendations!
0
Published in 2017 at "Brain Research"
DOI: 10.1016/j.brainres.2017.07.003
Abstract: Doxorubicin (DOX) is a potent chemotherapeutic agent known to cause acute and long-term cognitive impairments in cancer patients. Cognitive function is presumed to be primarily mediated by neuronal circuitry in the frontal cortex (FC) and…
read more here.
Keywords:
treatment;
glutamate neurotransmission;
frontal cortex;
dox ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Neurochemistry"
DOI: 10.1111/jnc.15238
Abstract: This Editorial highlights a remarkable study in the current issue of the Journal of Neurochemistry in which Hascup and coworkers provide novel data showing that riluzole, an antiāglutamatergic drug, may be a promising early intervention…
read more here.
Keywords:
targeting glutamate;
alzheimer disease;
glutamate neurotransmission;
strategy alzheimer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2019.01434
Abstract: Up to 50% of traumatic brain injury (TBI) survivors demonstrate persisting and late-onset anxiety disorders indicative of limbic system dysregulation, yet the pathophysiology underlying the symptoms is unclear. We hypothesize that the development of TBI-induced…
read more here.
Keywords:
traumatic brain;
anxiety;
glutamate neurotransmission;
like behavior ... See more keywords